Cart
sales@molnova.com
VBY-825
CAS No. 1310340-58-9
VBY-825( —— )
Catalog No. M26497 CAS No. 1310340-58-9
VBY-825 is a reversible inhibitor of cathepsin with high potency against cathepsins B, L, S and V.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 372 | Get Quote |
|
| 5MG | 620 | Get Quote |
|
| 10MG | 881 | Get Quote |
|
| 25MG | 1314 | Get Quote |
|
| 50MG | 1764 | Get Quote |
|
| 100MG | 2385 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameVBY-825
-
NoteResearch use only, not for human use.
-
Brief DescriptionVBY-825 is a reversible inhibitor of cathepsin with high potency against cathepsins B, L, S and V.
-
DescriptionVBY-825 is a reversible inhibitor of cathepsin with high potency against cathepsins B, L, S and V.(In Vitro):VBY-825 is a potent assayed cathepsins inhibitor and its potency against at least one cathepsin, cathepsin S, extends across species relevant for pharmacology studies, specifically mouse.(In Vivo):10 mg/kg/day dose of VBY-825 achieves a trough plasma concentration >200nM, which is well above that required for full inhibition of the intracellular activity of cathepsins B, F, K, L, S and V in both mouse and human cell lines.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetCysteine Protease
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1310340-58-9
-
Formula Weight535.55
-
Molecular FormulaC23H29F4N3O5S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (233.40 mM)
-
SMILESCC[C@H](NC(=O)[C@H](CS(=O)(=O)CC1CC1)N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)C(=O)NC1CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kimura M, Kimura I, Muroi M, Nojima H, Diwan PV. Depolarizing neuromuscular blocking action of coryneine derived from aconite root in isolated mouse phrenic nerve-diaphragm muscles. Biol Pharm Bull. 1995 May;18(5):691-5.
molnova catalog
related products
-
Liensinine Perchlora...
Liensinine is the active constituent of plumula nelambinis with anti-hypertension.
-
Cysteine protease in...
Cysteine protease inhibitor 2 is a cysteine protease inhibitor extracted from patent US20070032499A1, compound 12. Cysteine protease inhibitor 2 inhibited DCT116 and PC3 cells with GI50 values of 6.5 μM and 4.4 μM, respectively.
-
Isovalerylcarnitine
Isovalerylcarnitine (3-methylbutyrylcarnitine) is a small molecule compound produced by the catabolism of L-leucine and the accumulation of isovaleric acid.
